EPAS1 and neoplasm: Furthermore, the increased tumor progression seen in a KRAS-driven lung cancer model upon HIF2a depletion (i.e., HIF2a as a tumor suppressor) is in line with the CSPG4’s lack of pro-malignant features [42].